Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.5010
-0.0116 (-2.26%)
Nov 18, 2026, 12:58 PM EST - Market open
Invivyd Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 60.69 | 53.43 | 25.38 | - | - | - | |
Revenue Growth | 21.27% | 110.47% | - | - | - | - |
Cost of Revenue | 4.49 | 3.75 | 1.62 | - | - | - |
Gross Profit | 56.2 | 49.68 | 23.77 | - | - | - |
Selling, General & Admin | 103.51 | 66.93 | 63.39 | 49.13 | 47.04 | 36.52 |
Research & Development | 88.88 | 38.31 | 137.25 | 158.66 | 179.21 | 182.89 |
Operating Expenses | 192.39 | 105.24 | 200.64 | 207.78 | 226.26 | 219.41 |
Operating Income | -136.19 | -55.56 | -176.88 | -207.78 | -226.26 | -219.41 |
Interest & Investment Income | 5.99 | 3.11 | 7.22 | 7.36 | 3.9 | 1.7 |
Other Non Operating Income (Expenses) | -0.14 | -0.04 | -0.27 | -0.05 | -17.36 | -0.15 |
EBT Excluding Unusual Items | -130.33 | -52.49 | -169.93 | -200.47 | -239.72 | -217.86 |
Gain (Loss) on Sale of Investments | - | - | - | 6.8 | 2.8 | -1.43 |
Pretax Income | -130.33 | -52.49 | -169.93 | -198.64 | -241.32 | -226.79 |
Net Income | -130.33 | -52.49 | -169.93 | -198.64 | -241.32 | -226.79 |
Net Income to Common | -130.33 | -52.49 | -169.93 | -198.64 | -241.32 | -226.79 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 308 | 172 | 119 | 110 | 108 | 43 |
Shares Outstanding (Diluted) | 308 | 172 | 119 | 110 | 108 | 43 |
Shares Change | 132.09% | 45.26% | 8.24% | 1.16% | 154.02% | 1081.14% |
EPS (Basic) | -0.42 | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 |
EPS (Diluted) | -0.42 | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -134.11 | -58.29 | -170.63 | -173.78 | -221.69 | -184.82 |
Free Cash Flow Per Share | -0.44 | -0.34 | -1.44 | -1.59 | -2.05 | -4.34 |
Gross Margin | 92.60% | 92.99% | 93.63% | - | - | - |
Operating Margin | -224.42% | -103.99% | -696.80% | - | - | - |
Profit Margin | -214.77% | -98.25% | -669.42% | - | - | - |
Free Cash Flow Margin | -220.99% | -109.10% | -672.20% | - | - | - |
EBITDA | -135.5 | -54.81 | -175.41 | -207.3 | -226.22 | -219.41 |
EBITDA Margin | -223.29% | -102.58% | - | - | - | - |
D&A For EBITDA | 0.69 | 0.76 | 1.47 | 0.48 | 0.04 | 0 |
EBIT | -136.19 | -55.56 | -176.88 | -207.78 | -226.26 | -219.41 |
EBIT Margin | -224.42% | -103.99% | - | - | - | - |
Revenue as Reported | 60.69 | 53.43 | 25.38 | - | - | - |